| 1 |
|
| 2 |
|
| 3 |
Macaulay IC, Tijssen MR, Thijssen-Timmer DC, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins[J]. Blood, 2007, 109(8): 3260-3269. DOI: 10.1182/blood-2006-07-036269.
|
| 4 |
Bluteau D, Balduini A, Balayn N, et al. Thrombocytopeniaassociated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation[J]. J Clin Invest, 2014, 124(2):580-591. DOI: 10.1172/JCI71861.
|
| 5 |
Park M. Myelodysplastic syndrome with genetic predisposition[J]. Blood Res, 2021, 56(S1):34-38. DOI: 10.5045/br.2021.2020327.
|
| 6 |
Homan CC, Scott HS, Brown AL. Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26[J]. Blood, 2023, 141(13): 1533-1543. DOI: 10.1182/blood.2022017735.
|
| 7 |
Vyas H, Alcheikh A, Lowe G, et al. Prevalence and natural history of variants in the ANKRD26 gene: a short review and update of reported cases[J]. Platelets, 2022, 33(8):1107-1112. DOI: 10.1080/09537104.2022.2071853.
|
| 8 |
Bury L, Falcinelli E, Gresele P. Learning the ropes of platelet count regulation: inherited thrombocytopenias[J]. J Clin Med, 2021, 10(3): 533. DOI: 10.3390/JCM10030533.
|
| 9 |
Kwon SR, Kim MJ, Lee YE, et al. Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm[J]. Plos One, 2022, 17(12):e0271624. DOI: 10.1371/journal.pone.0271624.
|
| 10 |
|
| 11 |
Galera P, Dulau-Florea A, Calvo KR. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia[J]. Int J Lab Hematol, 2019, 41:131-141. DOI: 10.1111/ijlh.12999.
|
| 12 |
潘薇, 张思瑾, 徐晓恒, 等. 遗传性血小板减少症[J]. 中国实验诊断学, 2017, 21(01):169-173.
|
| 13 |
Pang C, Wu X, Nikuze L, et al. Analysis of clinical characteristics and treatment efficacy in two pediatric cases of ANKRD26-related thrombocytopenia[J]. Platelets, 2023, 34(1): 2262607. DOI: 10.1080/09537104.2023.2262607.
|
| 14 |
|
| 15 |
Cancio M, Hebert K, Kim S, et al. Outcomes in hematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia[J]. Transplant Cell Ther, 2022, 28(2):101.e1-101.e6. DOI: 10.1016/j.jtct.2021.10.009.
|
| 16 |
Husnain M, Wang T, Valdes M, et al. Multiple myeloma in a patient with ANKRD26-related thrombocytopenia successfully treated with combination therapy and autologous stem cell transplant[J]. Case Rep Hematol. 2019, 2019: 9357572. DOI: 10.1155/2019/9357572.eCollection2019.
|
| 17 |
|
| 18 |
Rabbolini DJ, Morel-Kopp MC, Stevenson W, et al. Inherited macrothrombocytopenias[J]. Semin Thromb Hemost. 2014, 40(7):774-784. DOI: 10.1055/s-0034-1387922.
|